Trump: Most-Favored-Nation Drug Pricing Being Extended to State Medicaid Programs
President Donald Trump announced Friday that the most-favored-nation (MFN) prices on prescription drugs in deals he struck with pharmaceutical companies are officially being extended to Medicaid programs in all 50 states, Washington, DC, an
Republican Ledger staff · 7:46 PM ET
Our newsroom is writing this report…
President Donald Trump announced Friday that the most-favored-nation (MFN) prices on prescription drugs in deals he struck with pharmaceutical companies are officially being extended to Medicaid programs in all 50 states, Washington, DC, and Puerto Rico. The post Trump: Most-Favored-Nation Drug Pricing Being Extended to State Medicaid Programs appeared first on Breitbart.
Recommended Stories
Trending nowJeff Bezos, Elon Musk and Sam Altman score invites to White House state dinner for Xi: ‘Hottest ticket in town’
NVIDIA President Jensen Huang, Google CEO Sundar Pichai, Dell Technologies founder Michael Dell and Citigroup CEO Jane Fraser are also invited.
Republican Ledger staff · 10:30 PM ET
PoliticsFlorida confirms death from dengue fever as state confronts growing outbreak
Florida health officials confirmed one death related to dengue fever on Friday as the state deals with one of the worst outbreaks related to the viral illness. The Florida Department of Health did not provide any specifics about the person
Republican Ledger staff · 9:04 PM ET
WorldCuba plunges into total blackout as electrical grid collapses again, US Embassy warns
Cuba's entire electrical grid collapsed Friday, triggering a nationwide blackout with cellphone and internet outages reported across the island.
Republican Ledger staff · 8:38 PM ET
PoliticsWhy the House let out early is a matter of debate after Johnson says chamber has 'done its work'
Thomas Massie claims Mike Johnson sent the House home early to dodge a vote on his eight privileged impeachment articles against Pete Hegseth.
Republican Ledger staff · 7:56 PM ET
Reader Discussion
0 comments- Loading comments…
